ERBB2 and breast cancer: Sertraline exhibited significant anticancer activity against HER2+ breast cancer cells through apoptosis induction and G2/M cell cycle arrestCytotoxicity in normal fibroblasts suggests potential side effects, highlighting the need for further mechanistic studies and in vivo validation before clinical application